AbbVie’s chief financial officer, Bill Chase, is ready to retire next year after heading up the company’s finances since it was born as an independent company in 2013. He’ll be replaced by current controller Robert Michael. More: AbbVie CFO Chase
read moreLilly’s Verzenio for hormone receptor-positive, HER2-negative breast cancer seems to work just as well as Pfizer’s Ibrance and Novartis’ Kisqali, England’s drug-price watchdog said, but Lilly didn’t make a plausible case that it’s more cost-effective. More: NICE spurns Lilly’s breast
read moreShire just nabbed FDA panel backing for prucalopride, aiming to challenge Allergan and Synergy in the chronic constipation market—and hoping to add blockbuster sales to a portfolio that’s at the heart of Takeda’s $62 billion buyout. More: Panel backing for
read moreMarketer of the Year will celebrate its 25th anniversary at The Tower Hotel, London on Thursday 15 November, alongside Communications Team of the Year and the all-new Sales Awards. More: A bumper networking opportunity Source: News
read moreInternational Clinical Researcher of the Year is celebrating its 20th anniversary in 2019. If ever there was a time to stand out against the competition and be remembered, it’s now! More: Have you entered yet? Source: News
read moreSanofi’s beleaguered dengue vaccine is expected to win EU approval in December after a key committee voted in favor of the shot. A safety scandal in the Philippines triggered a WHO review that narrowed Sanofi’s bid for European approval to
read more© 1994 - 2025 B.M. Pharmaceuticals